Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
100 hedge funds and large institutions have $127M invested in Calithera Biosciences, Inc in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 19 closing their positions.
92% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $598K
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 105 → 100 (-5)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
51% less capital invested
Capital invested by funds: $262M → $127M (-$135M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.82M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$3.51M |
| 3 |
ACM
Altium Capital Management
New York
|
+$2.48M |
| 4 |
BlackRock
New York
|
+$2.35M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$749K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.9M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.06M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.73M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.25M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$896K |
CALA Hedge Fund Activity: Q1 2021 in Review
100 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2021, worth a combined $127M — down 51% from $262M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CALA and 16 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 36 added.
The largest buyer was Adage Capital Partners, adding an estimated $5.82M. The largest seller was Wellington Management Group, exiting entirely with an estimated $11.9M sold.
- 100 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2021, down from 105 in Q4 2020.
- Funds reported $127M of Calithera Biosciences, Inc stock for Q1 2021, down 51% quarter-over-quarter.
- 16 funds opened new Calithera Biosciences, Inc positions in Q1 2021 and 19 closed out, a net change of -3 holders.
- The largest Calithera Biosciences, Inc buyer in Q1 2021 was Adage Capital Partners, an estimated $5.82M added.
- The largest Calithera Biosciences, Inc seller in Q1 2021 was Wellington Management Group, an estimated $11.9M sold.
Based on aggregated 13F filings for Q1 2021.